GHK-Cu is also known as:
- Copper tripeptide-1 (GHK-Cu)
- Copper peptide
- Glycyl-L-histidyl-L-lysine copper complex
- Copper-binding peptide
- Liver cell growth factor
- Wound healing factor
- Anti-aging factor
GHK-Cu is a naturally occurring tripeptide, meaning that it is made up of three amino acids: glycine, histidine, and lysine. The copper ion is bound to the histidine amino acid. GHK-Cu is found in human plasma, saliva, and urine.
GHK-Cu was first isolated in 1973 by Dr. Loren Pickart. Dr. Pickart was studying the effects of copper on wound healing, and he discovered that GHK-Cu was particularly effective in stimulating collagen production and promoting wound closure.
GHK-Cu has been shown to have a variety of biological effects, including:
- Wound healing: GHK-Cu stimulates the production of collagen and other extracellular matrix proteins, which are essential for wound healing. GHK-Cu also helps to attract and activate fibroblasts, which are the cells that play a key role in wound healing.
- Skin health: GHK-Cu increases collagen production, reduces inflammation, and protects against sun damage. GHK-Cu has been shown to be effective in treating a variety of skin conditions, including acne, rosacea, and eczema.
- Hair health: GHK-Cu stimulates the activity of hair follicles and prolongs the growing phase of the hair cycle. GHK-Cu has been shown to be effective in treating hair loss conditions such as alopecia areata.
- Anti-aging: GHK-Cu protects cells from damage and promotes tissue repair. GHK-Cu has been shown to reduce the appearance of wrinkles, fine lines, and age spots.
GHK-Cu is a safe and effective compound that can be used to improve health and well-being. It is available in a variety of forms, including topical creams and serums, oral supplements, and injectable products.
GHK-Cu is a promising compound with a wide range of potential therapeutic applications. More research is needed to confirm its safety and efficacy for the treatment of specific conditions in humans. However, the results of preclinical and clinical studies to date are encouraging.
If you are interested in learning more about GHK-Cu, please talk to your doctor.
